Cardiovasc Intervent Radiol (2018) 41:1716–1726 https://doi.org/10.1007/s00270-018-1991-3 CLINICAL INVESTIGATION INTERVENTIONAL ONCOLOGY Transarterial Radioembolization Following Chemoembolization for Unresectable Hepatocellular Carcinoma: Response Based on Apparent Diffusion Coefﬁcient Change is an Independent Predictor for Survival 1,2 1 3 • • • Elisabeth G. Klompenhouwer Raphae¨la C. Dresen Chris Verslype 4 1 1 • • • Annouschka Laenen Lawrence Bonne Vincent Vandecaveye Geert Maleux Received: 2 February 2018 / Accepted: 19 May 2018 / Published online: 5 June 2018 Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018 Abstract prior DEB-TACE procedures (p = 0.037), female gender Purpose To evaluate whether response based on contrast- (p \ 0.001) and BCLC C (p = 0.03) were related to worse enhanced magnetic resonance imaging (MRI) and apparent survival. The number of prior DEB-TACE procedure was diffusion coefﬁcient (ADC) change at diffusion-weighted signiﬁcantly higher in non-responders determined by MRI after transarterial radioembolization (TARE) can ADCratio (p = 0.028). Multivariable analyses showed that predict survival, in patients with prior transarterial response based on ADCratio was an independent predictor chemoembolization with drug-eluting beads (DEB-TACE) of survival (p = 0.041). for hepatocellular carcinoma (HCC). Conclusion ADCratio following TARE is an
CardioVascular and Interventional Radiology – Springer Journals
Published: Jun 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera